Who makes Implantable gestrinone?

Implantable gestrinone is developed by Bio Meds Pharmaceutica Ltda.

What development phase is Implantable gestrinone in?

Implantable gestrinone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Implantable gestrinone

Bio Meds Pharmaceutica Ltda · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Implantable gestrinone
Also known as	Gestrinone pellet
Sponsor	Bio Meds Pharmaceutica Ltda
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment (PHASE2)
Gestrinone and Endothelial Function in Young Women
Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Implantable gestrinone CI brief — competitive landscape report
Implantable gestrinone updates RSS · CI watch RSS
Bio Meds Pharmaceutica Ltda portfolio CI